In summary, we developed a GSH-responsive ICG loaded PD-1 inhibitory polypeptide AUNP12 modified MOF nanoparticles for achieving synergistic photothermal and immunotherapy in melanoma treatment. Here, PDCD1 is linked to melanoma.